Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Pricing and Reimbursement Strategies for Diagnostics: Overcoming Reimbursement Issues and Navigating the Regulatory Environment


      News provided by

      Reportlinker

      Nov 08, 2010, 01:18 ET

      Share this article

      Share this article


      NEW YORK, Nov. 8, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

      Pricing and Reimbursement Strategies for Diagnostics: Overcoming reimbursement issues and navigating the regulatory environment

      http://www.reportlinker.com/p0207237/Pricing-and-Reimbursement-Strategies-for-Diagnostics-Overcoming-reimbursement-issues-and-navigating-the-regulatory-environment.html

      The reimbursement for diagnostics is the key requirement for both the diagnostic providers and the payers because while 5-7% of the hospital cost is incurred on diagnostics, they are used for around 70% of the healthcare decisions. Developing an optimum price especially with respect to emerging diagnostic technologies such as molecular diagnostics has been very challenging as evidence-based pricing does not suffice for such technologies. This complicates the scenario for early movers in diagnostics. However, there has been an on-going issue even with respect to existing technologies, as the companies have an immense need to re-consider their pricing strategies to deal with cost and demand versus reimbursement issues. Hence, it is very crucial to identify novel pricing strategies to maintain a fair plane among all the stakeholders.

      Key features of this report

      • Regulatory structure for U.S. and Europe

      • Existing pricing strategies for healthcare diagnostic equipments

      • Novel pricing strategies for healthcare diagnostic equipments

      • Strategic recommendations for existing and first mover healthcare diagnostic equipments

      • Indicative prices and reimbursement amounts for healthcare diagnostic equipments

      Scope of this report

      •Understand the existing structure for reimbursements for healthcare diagnostic equipments developed markets

      • Understand the existing pricing for healthcare diagnostic equipments for developed markets

      • Understand the role of various factors impacting price of the healthcare diagnostic equipments

      • Understand the evolution of pricing strategies in recent times within healthcare diagnostic equipments

      • Helps in determining the complete understanding of changing times within pricing with respect to reimbursements

      Key Market Issues

      • The healthcare diagnostic industry is currently facing the issue of lack of reimbursements for various procedures which are extremely critical to patient diagnosis

      • This lack of reimbursements has started to affect the market negatively and the major markets in developed economies are seeing a negative to flat growth rate

      • Various end users are using this opportunity to push the prices of the healthcare diagnostic products further down, which can lead to decrease in the size of the industry

      • Various countries in Europe have their own reimbursement structure and policies with respect to various procedures. This is creating lot of bureaucratic and pricing hurdles for the Original Equipment Manufacturers (OEMs) of these products.

      • Various governments in Europe are changing their reimbursement policies with respect to new products launched within the healthcare diagnostic industry.

      Key findings from this report

      • A procedure might have a higher chance of getting insurance coverage, if it reduces the overall healthcare cost.

      • The recent reduction made by the CMS in the reimbursement amount for non-facility units is expected to impact the diagnostic devices market especially in the form of lack of innovation.

      • The reimbursement structure is restraining the growth of innovative technologies such as molecular diagnostics.

      • An OEM's pricing is fundamentally based on its desired Return-on-Investment and the overall cost of manufacturing its equipment.

      • Fair Value Pricing and Risk Sharing Pricing are the new methods of pricing within healthcare diagnostics

      Key questions answered

      • What is the existing reimbursement structure within the major markets in healthcare diagnostics?

      • What are existing pricing strategies employed by healthcare diagnostic Original Equipment Manufacturers (OEMs)?

      • What is the impact of current reimbursement policies over the pricing of healthcare diagnostic equipment pricing?

      • How do the OEMs of healthcare diagnostic equipments price their products considering reimbursement policies across the world?

      • What are the possible drawbacks of recent changes in reimbursement policies across the globe?

      Table of Contents

      Pricing and reimbursement strategies for diagnostics

      Executive Summary 10

      Market overview 10

      Key findings 11

      Analyzing best-fit strategies for novel pricing and reimbursement 13

      Strategic recommendations 14

      Chapter 1 Introduction 16

      Summary 16

      Key take aways 16

      Report description 16

      Stakeholders 17

      Chapter 2 Market overview 20

      Summary 20

      US regulations for medical devices & diagnostics 21

      United States Department of Health and Human Services (HHS) 22

      United States Public Health Services (PHS) 22

      National Institutes of Health (NIH) 22

      Agency for Healthcare Research and Quality 22

      Indian Health Services 22

      Substance Abuse and Mental Health Administration 23

      Centre for Disease Control and Prevention 23

      Food and Drug Administration 23

      US reimbursement structure 28

      US reimbursement payors 29

      Public health insurance 29

      Medicare 29

      Medicaid 29

      Other public systems 30

      Private health insurance 30

      Employer-sponsored insurance 30

      Administration 31

      Financing 31

      Private non-group (individual market) 31

      Overview 31

      Administration 31

      Financing 31

      US reimbursement procedures 32

      Benefit eligibility 32

      Billing process 34

      Coding systems 34

      Pricing processes 35

      Guidelines for coverage decision-making 36

      US diagnostic imaging reimbursement structure 37

      Medicare perspective 37

      European healthcare reimbursement structure 38

      European healthcare regulatory structure 38

      German healthcare system 40

      Impact of regulations on pricing and reimbursement 43

      French healthcare system 44

      Impact of regulations on pricing and reimbursement 48

      UK healthcare system 49

      Impact of regulations on pricing and reimbursement 52

      Italian healthcare system 53

      Impact of regulations on pricing and reimbursement 55

      Spanish healthcare system 55

      Impact of regulations on pricing and reimbursement 58

      European diagnostic imaging reimbursement structure 58

      Pricing and reimbursement: pharmaceutical vs. diagnostics 58

      Level of pricing transparency for diagnostic devices 60

      Chapter 3 Key findings 64

      Summary 64

      Introduction 65

      Impact analysis: role of pricing in risk minimization 65

      Payor's (health insurance companies) perspective 68

      Diagnostic provider's perspective 69

      Identifying critical issues in the pricing and reimbursement of diagnostics 71

      Decline in the reimbursement for non-facility units in US 71

      Evolving molecular diagnostics causing further complications 72

      Factors affecting price of healthcare diagnostic products 73

      Competition: 75

      Company Profile in the local market: 78

      Government: 79

      Reimbursements 80

      Chapter 4 Analyzing best-fit strategies for novel P&R issues 84

      Summary 84

      Introduction 85

      Pricing strategy 85

      Price management and reassessment of pricing throughout the product lifecycle 87

      Existing product technologies 89

      New product (first mover diagnostic) technologies 90

      Payor engagement strategy 90

      Introduction of separate business unit for pricing and reimbursement 92

      Novel pricing for existing and first mover diagnostic technologies to overcome reimbursement issues 93

      Fair value pricing 94

      Risk based pricing 94

      Outsourcing pricing & reimbursement strategies 96

      Universal pricing 97

      Free pricing 97

      Strategic recommendations 98

      Innovations to demand a price premium 98

      Case study – Average selling price of mammography units 98

      Reduced time to market to generate faster ROI 100

      Technologies addressing unmet clinical needs to benefit diagnostics providers 100

      Chapter 5 Appendix 104

      Index 125

      List of Figures

      Figure 2.1: US healthcare regulatory organizational chart 21

      Figure 2.2: US FDA organizational chart 24

      Figure 2.3: CDRH Organization Chart 25

      Figure 2.4: US healthcare reimbursement and financing structure 28

      Figure 2.5: Healthcare structure in Germany 40

      Figure 2.6: Healthcare structure in France 44

      Figure 2.7: Healthcare structure in the UK 49

      Figure 2.8: Healthcare structure in Italy 53

      Figure 2.9: Healthcare structure in Spain 55

      Figure 3.10: Reimbursement mechanism 67

      Figure 3.11: Different cases for reimbursement approvals 69

      Figure 3.12: Factors affecting pricing in a healthcare diagnostic OEM 73

      Figure 3.13: Pricing work flow in a healthcare diagnostic OEM 74

      Figure 3.14: Pricing equation 75

      Figure 3.15: Product lifecycle for a diagnostic product 76

      Figure 4.16: Value-based pricing & reimbursement 86

      Figure 4.17: Product lifecycle (PLC) for a diagnostic product 88

      Figure 4.18: Price recommendations at Product Lifecycle (PLC) stages 89

      Figure 5.19: Mammography: Average selling price ($)for U.S., 2005-10 99

      List of Tables

      Table 2.1: Payment & coverage in pharma 59

      Table 3.2: Reduction in US. medical procedure reimbursement 71

      Table 6.3: Indicative prices for in vitro diagnostic equipment – US 104

      Table 6.4: Indicative reimbursement for in vitro diagnostic tests – US 105

      Table 6.5: Indicative reimbursement for in vitro diagnostic tests – US (contd. 1) 106

      Table 6.6: Indicative reimbursement for in vitro diagnostic tests – US (contd. 2) 107

      Table 6.7: Indicative reimbursement for in vitro diagnostic tests – US (contd. 3) 108

      Table 6.8: Indicative reimbursement for in vitro diagnostic tests – US (contd. 4) 109

      Table 6.9: Indicative reimbursement for in vitro diagnostic tests – US (contd. 5) 110

      Table 6.10: Indicative reimbursement for in vitro diagnostic tests – US (contd. 6) 111

      Table 6.11: Indicative reimbursement for in vitro diagnostic tests – US (contd. 7) 112

      Table 6.12: Indicative reimbursement for in vitro diagnostic tests – US (contd. 8) 113

      Table 6.13: Indicative reimbursement for toxicology/DAU (Drugs of Abuse) tests 114

      Table 6.14: Indicative reimbursement for toxicology/DAU (Drugs of Abuse) tests 115

      Table 6.15: Indicative reimbursement for toxicology/DAU (Drugs of Abuse) tests 116

      Table 6.16: Indicative reimbursement for toxicology/DAU (Drugs of Abuse) tests 117

      Table 6.17: Indicative reimbursement for point of care tests 118

      Table 6.18: Indicative reimbursement for Microalbumin and Creatinine tests 119

      Table 6.19: Indicative Reimbursement for various kind of Hemoglobin tests 120

      Table 6.20: Indicative prices for in vivo diagnostic equipment ($) – US 120

      Table 6.21: Indicative reimbursement for in-vivo diagnostic tests – US 121

      Table 6.22: Medicare reimbursement for mammography services 122

      Table 6.23: Medicare reimbursement for mammography services 123

      Table 6.24: 2005 Medicare payment for magnetic resonance imaging of the joints of the extremities 123

      Table 6.25: 2007 Medicare reimbursement for SPECT/CT for selected tumor imaging and localization 124

      To order this report:

      Diagnostics Industry: Pricing and Reimbursement Strategies for Diagnostics: Overcoming reimbursement issues and navigating the regulatory environment

      More  Market Research Report

      Check our  Company Profile, SWOT and Revenue Analysis!

      Contact Nicolas Bombourg

      Reportlinker

      Email: [email protected]

      US: (805)652-2626

      Intl: +1 805-652-2626



      SOURCE Reportlinker

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.